About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Improved Vaccine for Bacterial Meningitis, Bloodstream Infections Developed

by Iswarya on June 29, 2019 at 11:16 AM
Font : A-A+

Improved Vaccine for Bacterial Meningitis, Bloodstream Infections Developed

New native outer membrane vesicle (NOMV) vaccine developed for meningitis and bloodstream infections caused by 'meningococcal group B' bacteria will allow younger people to be vaccinated and addresses several limitations of the current vaccinations. The findings of the study are published in the journal mBio.

"We developed the improved version of the vaccine by making several genetic changes to the strain of bacteria used to produce the vaccine, resulting in a broadly protective vaccine rather than a strain-specific vaccine," said Peter Beernink, Ph.D., Scientist at the Center for Immunobiology and Vaccine Development, Benioff Children's Hospital Oakland.

Advertisement


There are currently only two licensed vaccines for prevention of meningitis and bloodstream infections caused by "meningococcal group B" bacteria, which are only licensed for use in people age ten years and older. Both vaccines contain a bacterial protein known as Factor H binding protein (FHbp), which can bind to a host protein known as Factor H (FH). 

The licensed vaccines have several limitations, which include lack of effectiveness against some bacterial strains and low immune responses of infant humans.
Advertisement

The researchers immunized infant rhesus monkeys with the NOMV-FHbp vaccine, which induced higher levels of protective serum antibodies than a licensed vaccine against five of six bacterial strains tested. 

Two macaques immunized with the licensed vaccine, which contains FHbp that binds macaque FH, developed antibodies to the host FH protein whereas none of the animals given the NOMV-FHbp vaccine or a negative control vaccine developed such antibodies.

The monkey antibody responses to the vaccines were measured in the laboratory based on the ability of serum antibodies to kill the bacteria in a test that is widely considered to predict protection in humans.  The sample sizes of animals were chosen, such that the results are highly statistically significant.

"The experimental NOMV vaccine extends the approach of using outer membrane vesicle vaccines, which previously have been given to millions of persons during meningitis B epidemics in Norway, Cuba and New Zealand," said Beernink.

Thus, in a relevant infant non-human primate model, the NOMV-FHbp vaccine elicited higher levels of protective antibodies than the licensed vaccine and anti-FH antibodies in fewer animals. "This shows that the vaccine has the potential to be developed into a more broadly protective vaccine for humans, to extend coverage to infants and toddlers, which are the age groups among the highest risk of developing the meningococcal disease, and to increase vaccine safety," said Beernink.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ten Fruits for Diabetics
Natural Supplements Help Reverse Hair Loss during Menopause
Ways to Manage Stress during COVID-19 Pandemic
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Vaccination for Children Top 10 Vaccine Myths Debunked Therapeutic Drug Monitoring 

Recommended Reading
Bacterial Meningitis
Bacterial infection that causes inflammation of the membranes of the brain, is called bacterial ......
Cryptococcal Meningitis
Cryptococcal meningitis is a fungal infection affecting the coverings of the brain (meninges). It .....
Non-Antibiotic Therapeutic Option for Bacterial Meningitis
There is a need for discovering new treatment strategies against life-threatening bacterial ......
Meningitis Bacteria Change Key Protein Shape to Escape Detection
Bacterial meningitis seems to crop up out of nowhere in the US every once in a while...
Therapeutic Drug Monitoring
Therapeutic drug monitoring is measuring drug concentrations at specific intervals in a patient's bl...
Top 10 Vaccine Myths Debunked
Childhood vaccination has saved many lives, yet lots more has to be done to increase awareness and e...
Vaccination for Children
Vaccines are biological products that impart immunity to the recipient. Vaccines may be live attenua...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use